Rimonabant cuts rate of metabolic syndrome by 53%: selective endocannabinoid rank 1 receptor blocker improves weight loss, lipid profile.(Hearsay)(selective … An write-up from: Internal Medicine Hearsay This digital paper is an write-up from Internal Medicine Hearsay, published by International Medical Hearsay Assemble on October 1, 2004. The length of the write-up is 1489 terms. The [...]